RESEARCH-USE BIOSIMILAR ANTIBODY

Prolgolimab

Monoclonal antibody · IgG1

PDCD1IgG1RUO

Prolgolimab (BCD-100) is a human IgG1 anti-PD-1 monoclonal antibody containing the Fc-silencing 'LALA' mutation. Prolgolimab can be used for the research of advanced melanoma.

TARGETPDCD1
YMonoclonal antibody
CATALOGSC-BS-258
CATALOG NUMBERSC-BS-258
MOLECULAR WEIGHTApprox. 146.28 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Prolgolimab (BCD-100) is a human IgG1 anti-PD-1 monoclonal antibody containing the Fc-silencing 'LALA' mutation. Prolgolimab can be used for the research of advanced melanoma.

Prolgolimab is a recombinant research-use antibody directed against PDCD1.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Prolgolimab | StellaCyte